Biotech

InvestorNews.com is pleased to announce an upcoming InvestorTalk scheduled for tomorrow, Wednesday, June 25th, at 9 AM EST, featuring Brent Willis, President, CEO,…

InvestorNews

June 24, 2025

No Comments

Biotech, Critical Minerals & Rare Earths

Brent Willis to Spotlight “Radiology’s Hidden Critical Minerals Crisis—And How Voyageur Is Solving It” at CMI Summit IV

TORONTO, ONTARIO – May 8, 2025 – The Critical Minerals Institute (CMI) is delighted to announce that Brent…

InvestorNews

May 8, 2025

No Comments

Biotech

From Brine to Bottle: Voyageur Pharmaceuticals Bets on the Mueller Process in the Iodine Contrast Market

From Brine to Bottle: Voyageur Pharmaceuticals Bets on the Mueller Process in the Iodine Contrast Market

Spoofing Allegations Against Banks Take Center Stage in Biotech’s Legal Fight

Lixte’s Big Bet: Making Other Cancer Drugs Work Harder

InvestorTalk Alert: Brent Willis from Voyageur Pharmaceuticals Ltd. to host on Tuesday, December 9, 2025

InvestorTalk Alert: Andre Larente from Diagnos Inc. to host on Tuesday, October 7, 2025

The Magic in the Voyageur Model—Own the Rock, Control the Chemistry, Bottle the Contrast Agent.

Cardiol Therapeutics’ Cannabidiol Formulation Reduced Inflammation—Phase II Topline Data Ignites the Race to Treat Acute Myocarditis

Voyageur Advances Mine-to-Bottle Strategy for Critical Mineral Barium and Iodine Contrast Products

InvestorTalk Alert: Brent Willis from Voyageur Pharmaceuticals Ltd. to host on Wednesday, June 25, 2025 at 9 AM EST

Brent Willis to Spotlight “Radiology’s Hidden Critical Minerals Crisis—And How Voyageur Is Solving It” at CMI Summit IV

Venezuela’s Resource Paradox: Critical Minerals, Oil, and the Price of Mismanagement

The Greenland Critical Minerals (and Rare Earths) Myth, Dispelled

The Critical Minerals Report (01.11.2026): The World’s Scramble for Critical Minerals Enters a New Phase

InvestorNews Member News

DIAGNOS Advances Regulatory Strategy for CARA in Key Markets: Updates on Health Canada, FDA, and SFDA Progress

Voyageur Pharmaceuticals Strengthens Scientific Team by Adding Dr. Brian Mueller as Director of Chemistry and Secures Exclusive Ownership of Iodine Extraction Technology

Lixte Biotechnology Holdings, Inc. Announces $4.3 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules

LIXTE Biotechnology Acquires Liora Technologies’ Proprietary Proton Therapy Platform for Cancer Treatment

ENTO Subsidiary Grid AI Announces Letter of Intent with First Hyperscaler AI Data-Center Customer

InvestorNews Interviews

Why Tungsten Has Jumped to No. 1 on the World’s Critical Minerals Hot List

Energy Fuels and Australian Strategic Materials Unite to Build a New Rare Earths Powerhouse for Western Markets

Christopher Ecclestone with Scandium Canada’s Guy Bourassa on One of the World’s Leading Primary Scandium Resources

Quantum Critical Metals’ Marcy Kiesman on Advancing Gallium and Rubidium in the Critical Minerals Race

Biotech

Daily InvestorNews updates

InvestorNews Interviews

Why Tungsten Has Jumped to No. 1 on the World’s Critical Minerals Hot List

Energy Fuels and Australian Strategic Materials Unite to Build a New Rare Earths Powerhouse for Western Markets

Christopher Ecclestone with Scandium Canada’s Guy Bourassa on One of the World’s Leading Primary Scandium Resources

Quantum Critical Metals’ Marcy Kiesman on Advancing Gallium and Rubidium in the Critical Minerals Race